Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

Strategies to strengthen the distribution system to improve the availability of medicine Dr Wael Inmair Director Assistant, Central Medical Supply Store,
Strategies to Improve Efficiency in Medicine Procurement Towards equitable and affordable medicine prices policies in Jordan Workshop 4-5 Dec, 2007 Dr.
MDG Target 8.E gap analysis Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical Policies, World Health Organization 27 August 2008.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Priority Issues and Strategic Information Needs for Kenya in scaling up ART.
TITLE from VIEW and SLIDE MASTER | 27 July |1 | Future of Essential Medicines Kenya National Drug Policy Implementation Programme (KNDIP)
World Health Organization
Alessandro de Luca Senior Vice President MERCK Group
MEDICINES SELECTION & FORMULARY MANAGEMENT
Pharmaceuticals Procurement and Supply Management: The case of Ethiopia Cambodia, December 4,
Presentation to the 2014 International AIDS Conference
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Abstract 213 ICIUM: Antalya, Turkey. November 14-18, 2011.
Pharmaceutical Services Unit Essential Medicines Management MoH Procurement of Essential Medicines Presented by Mildred Mulenga Pharmacist, MoH 1.
Entrenching the KNH Formulary to Clinical Practice DR WK SIGILAI MTC CHAIR.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Managing Risk and Overcoming Health Systems Bottlenecks in Haiti Emerging Lessons Jessica Faieta - Senior Country-Director, UNDP/Haiti & Dr Joelle Deas.
National Medicine Policy
Health Planning and Implementation in post-conflict Afghanistan by Laurence Laumonier-Ickx, MD November 8, 2006.
UK Policy considerations on increasing access to medicines for the poor in developing countries. DEPARTMENT FOR INTERNATIONAL DEVELOPMENT.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
Forging Partnerships at Country Level to Achieve Contraceptive Security: Reproductive Health Supplies in Six Countries Elizabeth Leahy Madsen and Karen.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Issues of Access to Medicines in Swaziland Fortunate Fakudze The Royal Villas, Ezulwini 13 th October 2014.
Partnering initiatives to stop TB at country level Inclusive platform for all partners interested and working for TB prevention, care, control Different.
Roadmap to Achieve RBM Targets September 2009 – December 2010 Ghana.
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Kenya Roadmap to Achieve RBM Targets September 2009 – December 2010.
1 CLUSTER : Pharmaceutical Policy & Planning Strategic Plans 2004/ /6 2006/7 31 May 2004.
WHO Prequalification of Medicines: a gateway to the global pharmaceutical market Introduction 28 June 2014, Shanghai Milan Smid.
Procurement &supply chain management 5 th Joint International Monitoring Mission.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
The WHO Prequalification of Medicines Program - Introduction Tony Gould Manager, Prequalification of Medicines Program WHO.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Taxonomy of Strategies
THE OVERVIEW OF THE HEALTH SECTOR IN SOUTH AFRICA
WHO Medicines Work in Countries: The Kenya Example
Malaria Programmes and Implication on Strengthening the overall Health System Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines.
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.
Richard Laing EMP/WHO TBS 2012
Accessing Medicines in Africa Prospects and challenges
National Medicines Policies
Group One How would we increase the alignment of the SDG’s with The National Development Plan (NDP).
Richard Laing WHO/PAU TBS 2013
WHO Global HIV/AIDS Staff Meeting
Access to Essential Medicines
Prequalification Programme of Medicines (PQP): Introductory messages
Interventions in the Kosovo Pharmaceutical Sector: Success or Failure?
National Medicines Policies
Presentation transcript:

Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now

Now : Essential Medicines programmes In 2010, health expenditures The public per capita expenditure is US$ 40,

Now: NDP The NDP is increasingly act as a framework for managing the pharmaceutical sector.

Now: Essential Medicines It guides the procurement of medicines in the public sector, health insurance, donations, and local medicine production. It is part of training programme of graduated pharmacists. Today, both public tender prices and C&F prices for private sector are publically available in websites.

Now: Public Supply System Management system improved significantly – Computerized system at central – SOPs and adherence to basic standards in drug supply management – Monitoring and evaluation systems, – Managerial auditing system Delivery to states through RDF project – Branch in each state with 8% less in price;

Now: Health Insurance – Coverage is only 30% of population; – Based on essential medicines; – Patient pay 25% of the treatment cost; – Branch in each state

Now: Health Partners Obtaining health partners and donors support to expand the drug supply & management component; – GF delivering free medicines for the TB, HIV and Malaria – programmes for control neglected and communicable diseases e.g Meningitis outbreaks, – EPI, – RH EHA, in areas where the Government is not available

In 2007, the availability essential medicines in public sector was 86% and 95% in private sector In 2010, availability of essential medicines at public sector was 80.6%, and in private sector was 93.0% Now: Availability In 2007, only 67 % are affordable.

Now: RUM In 2007; 73% of prescribed medicines in public sector were from the EML, 45% were prescribed by generic name

Now: Regulations essential medicines In 2007, independent MRA was established and Policies separated from regulations; With support of WHO/EC roadmap for QC PQ is in place since Pharmaco-vigilance unit established in 2009; Being Uppsala member supported by EC

Other changes WHO Good Governance started in 2010 Pharmaceutical Country Profile, in 2010 Global Fund Project for 5-years support Licensed pharmacists was 1.53/10,000 compared to 0.5/10,000 in 1990, HR mapping was conducted – framework for HRD developed;

Challenges 1.Fragmented health system, with inequitable distribution of resources; – Verticality of supplies by different programme 2.Instability of policies towards public supply system; 3.Poor data and information management system; 4.Efficacy and quality, yet is a question; 5.Distribution and delivery at state level; 6.Accessibility is still low; 7.Low coverage of health insurance; 8.Irrational use of medicines (36% of health expenditures); 9.Capacities to adsorb all available budgets is limited; 10.Policies implementation and monitoring

Thank you